Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients: A Prospective Multicenter Clinical Study Based on Randomized Intra-individual Implant Activation in Patients With Degenerative Retinal Diseases
Sponsor: Retina Implant AG
This NA trial investigates Retinal Degeneration and Retinitis Pigmentosa and is currently completed. Retina Implant AG leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Completed → Active Not Recruiting
-
Jun 2017 — Oct 2017 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Retina Implant AG
For direct contact, visit the study record on ClinicalTrials.gov .